Showing results (201-210 of 352) with videos related to

Sort By:
Pageof 36
Health Affairs (Project Hope)|November 4, 2024
Small-Molecule Drugs Offer Comparable Health Benefits To Biologics At Lower CostsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
Radiology|June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer diseasePamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.
Health Affairs (Project Hope)|November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug CoverageJames D Chambers, Ari D Panzer, Elle F Pope, et al.
Headache|August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatmentJeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.
The American Journal of Managed Care|April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare systemPeter J Neumann, Jennifer A Palmer, Norman Daniels, et al.
Health Affairs Scholar|July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan DrugsKatherine A Clifford, A Alex Levine, Daniel E Enright, et al.
Pageof 36